Raghavachar A, Sulc K, Fliedner T M
Blut. 1982 Feb;44(2):107-10. doi: 10.1007/BF00320098.
DXM application in dogs in an amount of 0.3 or 0.6 mg/kg b.w. results in a very transient increase of CFU-C within 1 h after administration and a subsequent progressive decrease of circulating CFU-C reaching a nadir at about 7 h. The pattern seen in the blood CFU-C concentration matches the pattern of change seen in the total lymphocyte population. The CFU-C changes observed do not correspond to the change of the PMN numbers in the peripheral blood after DXM. There is a 3 fold increase in the number of circulating PMNs. The data suggest that the blood CFU-C follow in principle the pattern of the other mononuclear cells, usually described as "lymphocytes". The pattern of change of CFU-C and lymphocytes however must not be interpreted to mean that the pathophysiological mechanisms behind this changes are the same considering the CFU-C population and the other lymphocyte populations.
以0.3或0.6毫克/千克体重的剂量给犬应用地塞米松(DXM),给药后1小时内循环祖细胞集落形成单位(CFU-C)会出现非常短暂的增加,随后循环CFU-C逐渐减少,在约7小时时降至最低点。血液中CFU-C浓度的变化模式与总淋巴细胞群体的变化模式相匹配。观察到的CFU-C变化与地塞米松给药后外周血中多形核白细胞(PMN)数量的变化不对应。循环PMN数量增加了3倍。数据表明,血液CFU-C原则上遵循其他单核细胞(通常称为“淋巴细胞”)的变化模式。然而,CFU-C和淋巴细胞的变化模式不能被解释为意味着考虑到CFU-C群体和其他淋巴细胞群体,这种变化背后的病理生理机制是相同的。